

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of interleukin-12 production (GO:0032695) | 5.01100885 |
| 2 | detection of molecule of bacterial origin (GO:0032490) | 4.40708802 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.40407639 |
| 4 | negative regulation of cell killing (GO:0031342) | 4.39892578 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.39892578 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.36921720 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.36921720 |
| 8 | modulation by symbiont of host immune response (GO:0052553) | 4.36921720 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 4.36921720 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 4.36921720 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.36921720 |
| 12 | detection of other organism (GO:0098543) | 4.30698897 |
| 13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.14811242 |
| 14 | sarcomere organization (GO:0045214) | 4.06664998 |
| 15 | detection of external biotic stimulus (GO:0098581) | 4.00858453 |
| 16 | detection of bacterium (GO:0016045) | 3.98711825 |
| 17 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.79627266 |
| 18 | neutrophil activation involved in immune response (GO:0002283) | 3.65744066 |
| 19 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.64718496 |
| 20 | macrophage activation involved in immune response (GO:0002281) | 3.63896208 |
| 21 | T-helper 1 type immune response (GO:0042088) | 3.58890059 |
| 22 | regulation of relaxation of muscle (GO:1901077) | 3.54088772 |
| 23 | detection of biotic stimulus (GO:0009595) | 3.53661740 |
| 24 | positive regulation of interferon-alpha production (GO:0032727) | 3.46014947 |
| 25 | response to host immune response (GO:0052572) | 3.43926278 |
| 26 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.43926278 |
| 27 | response to peptidoglycan (GO:0032494) | 3.42799637 |
| 28 | cardiac myofibril assembly (GO:0055003) | 3.37245899 |
| 29 | cellular response to zinc ion (GO:0071294) | 3.36587166 |
| 30 | regulation of mast cell degranulation (GO:0043304) | 3.36078630 |
| 31 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.35440113 |
| 32 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.28991086 |
| 33 | NIK/NF-kappaB signaling (GO:0038061) | 3.25478410 |
| 34 | regulation of interferon-alpha production (GO:0032647) | 3.25441308 |
| 35 | germinal center formation (GO:0002467) | 3.21973116 |
| 36 | microglial cell activation (GO:0001774) | 3.21342997 |
| 37 | positive regulation of antigen processing and presentation (GO:0002579) | 3.20359821 |
| 38 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.17054934 |
| 39 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.16136513 |
| 40 | response to host (GO:0075136) | 3.16136513 |
| 41 | response to host defenses (GO:0052200) | 3.16136513 |
| 42 | myofibril assembly (GO:0030239) | 3.15865153 |
| 43 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.15224074 |
| 44 | positive regulation of mast cell activation (GO:0033005) | 3.14152634 |
| 45 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.14052500 |
| 46 | respiratory burst (GO:0045730) | 3.08756421 |
| 47 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.08110730 |
| 48 | immunoglobulin mediated immune response (GO:0016064) | 3.07753904 |
| 49 | leukocyte aggregation (GO:0070486) | 3.06732947 |
| 50 | regulation of gamma-delta T cell activation (GO:0046643) | 3.05779268 |
| 51 | regulation of leukocyte degranulation (GO:0043300) | 3.04900410 |
| 52 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.03537685 |
| 53 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.03149735 |
| 54 | regulation of cell communication by electrical coupling (GO:0010649) | 3.02982665 |
| 55 | B cell mediated immunity (GO:0019724) | 3.02546798 |
| 56 | defense response to protozoan (GO:0042832) | 3.00567696 |
| 57 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.00548057 |
| 58 | glycosphingolipid catabolic process (GO:0046479) | 2.98827285 |
| 59 | regulation of actin filament-based movement (GO:1903115) | 2.98686190 |
| 60 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.98530517 |
| 61 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.96548621 |
| 62 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.96141902 |
| 63 | positive regulation of mast cell degranulation (GO:0043306) | 2.96141902 |
| 64 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.93802125 |
| 65 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.91359885 |
| 66 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.91083955 |
| 67 | regulation of mast cell activation (GO:0033003) | 2.89113198 |
| 68 | response to protozoan (GO:0001562) | 2.87552854 |
| 69 | cytidine metabolic process (GO:0046087) | 2.87545838 |
| 70 | cytidine catabolic process (GO:0006216) | 2.87545838 |
| 71 | cytidine deamination (GO:0009972) | 2.87545838 |
| 72 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.85342982 |
| 73 | positive regulation of leukocyte degranulation (GO:0043302) | 2.85041603 |
| 74 | regulation of podosome assembly (GO:0071801) | 2.83172943 |
| 75 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.83161784 |
| 76 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.81394363 |
| 77 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.80758344 |
| 78 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.80237677 |
| 79 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.79307298 |
| 80 | regulation of T cell tolerance induction (GO:0002664) | 2.78862226 |
| 81 | granulocyte activation (GO:0036230) | 2.78737844 |
| 82 | neutrophil activation (GO:0042119) | 2.78647472 |
| 83 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.78542046 |
| 84 | positive regulation of type 2 immune response (GO:0002830) | 2.78445335 |
| 85 | striated muscle atrophy (GO:0014891) | 2.78052991 |
| 86 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.77839767 |
| 87 | cellular extravasation (GO:0045123) | 2.77796735 |
| 88 | heart contraction (GO:0060047) | 2.77702402 |
| 89 | heart process (GO:0003015) | 2.77702402 |
| 90 | regulation of antigen processing and presentation (GO:0002577) | 2.76082155 |
| 91 | muscle filament sliding (GO:0030049) | 2.75574225 |
| 92 | actin-myosin filament sliding (GO:0033275) | 2.75574225 |
| 93 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.75355090 |
| 94 | neutrophil mediated immunity (GO:0002446) | 2.74784271 |
| 95 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.74595567 |
| 96 | macrophage activation (GO:0042116) | 2.73922857 |
| 97 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.73881794 |
| 98 | glycolipid catabolic process (GO:0019377) | 2.73565461 |
| 99 | amino sugar catabolic process (GO:0046348) | 2.71348667 |
| 100 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.71290719 |
| 101 | myeloid dendritic cell activation (GO:0001773) | 2.70685414 |
| 102 | regulation of skeletal muscle contraction (GO:0014819) | 2.70466761 |
| 103 | relaxation of cardiac muscle (GO:0055119) | 2.70331678 |
| 104 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.70280277 |
| 105 | neutrophil chemotaxis (GO:0030593) | 2.70178319 |
| 106 | oligosaccharide catabolic process (GO:0009313) | 2.70060438 |
| 107 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.68117112 |
| 108 | cardiac muscle contraction (GO:0060048) | 2.67381678 |
| 109 | myeloid leukocyte activation (GO:0002274) | 2.67240749 |
| 110 | * interferon-gamma-mediated signaling pathway (GO:0060333) | 2.66358781 |
| 111 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.66292254 |
| 112 | regulation of tolerance induction (GO:0002643) | 2.66132888 |
| 113 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.65667493 |
| 114 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.64934755 |
| 115 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.64483082 |
| 116 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.64383565 |
| 117 | plasma membrane repair (GO:0001778) | 2.64295137 |
| 118 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.64191044 |
| 119 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.62898107 |
| 120 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.62898107 |
| 121 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.62874559 |
| 122 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.61901135 |
| 123 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.60711768 |
| 124 | skeletal muscle adaptation (GO:0043501) | 2.57822603 |
| 125 | actomyosin structure organization (GO:0031032) | 2.57619490 |
| 126 | response to type I interferon (GO:0034340) | 2.56744242 |
| 127 | myeloid cell activation involved in immune response (GO:0002275) | 2.54280170 |
| 128 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.54256774 |
| 129 | cellular response to type I interferon (GO:0071357) | 2.53972806 |
| 130 | type I interferon signaling pathway (GO:0060337) | 2.53972806 |
| 131 | lymphocyte chemotaxis (GO:0048247) | 2.53211500 |
| 132 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.50814706 |
| 133 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.50273848 |
| 134 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.48646984 |
| 135 | positive regulation of macrophage cytokine production (GO:0060907) | 2.48501713 |
| 136 | superoxide anion generation (GO:0042554) | 2.47447075 |
| 137 | response to muramyl dipeptide (GO:0032495) | 2.45922624 |
| 138 | cell adhesion mediated by integrin (GO:0033627) | 2.42527842 |
| 139 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.42117836 |
| 140 | regulation of monocyte chemotaxis (GO:0090025) | 2.41165571 |
| 141 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.39481748 |
| 142 | reactive oxygen species biosynthetic process (GO:1903409) | 2.39245756 |
| 143 | muscle hypertrophy (GO:0014896) | 2.38195992 |
| 144 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.38110293 |
| 145 | pinocytosis (GO:0006907) | 2.37996835 |
| 146 | regulation of striated muscle contraction (GO:0006942) | 2.37477548 |
| 147 | regulation of mononuclear cell migration (GO:0071675) | 2.35826202 |
| 148 | regulation of macrophage cytokine production (GO:0010935) | 2.35215100 |
| 149 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.34190102 |
| 150 | regulation of sarcomere organization (GO:0060297) | 2.33291301 |
| 151 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.33267148 |
| 152 | myeloid dendritic cell differentiation (GO:0043011) | 2.32445896 |
| 153 | actin nucleation (GO:0045010) | 2.32265039 |
| 154 | actin-mediated cell contraction (GO:0070252) | 2.31976387 |
| 155 | I-kappaB phosphorylation (GO:0007252) | 2.30239081 |
| 156 | dendritic cell chemotaxis (GO:0002407) | 2.30218171 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.25373318 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.23408289 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.14283389 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.19516202 |
| 5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.01031431 |
| 6 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.75312726 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.70398539 |
| 8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.68453650 |
| 9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.68088057 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.54464260 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.52067717 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.49319521 |
| 13 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.42090921 |
| 14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.39275352 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.30648503 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.20853622 |
| 17 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.18462995 |
| 18 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.16391371 |
| 19 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.11029018 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.04118399 |
| 21 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.01526799 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.95774783 |
| 23 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.91033138 |
| 24 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.89167199 |
| 25 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.78960839 |
| 26 | SPI1_23127762_ChIP-Seq_K562_Human | 1.72792546 |
| 27 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.67566554 |
| 28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.67380752 |
| 29 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.64807062 |
| 30 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.61514667 |
| 31 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.61448692 |
| 32 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.55154584 |
| 33 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.53837325 |
| 34 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.48485869 |
| 35 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.47682599 |
| 36 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.46504618 |
| 37 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.46208700 |
| 38 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.45227525 |
| 39 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.45223823 |
| 40 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.44687647 |
| 41 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.39845591 |
| 42 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.39251892 |
| 43 | UTX_26944678_Chip-Seq_JUKART_Human | 1.38865988 |
| 44 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.38240936 |
| 45 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.38240936 |
| 46 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.37868833 |
| 47 | MYC_22102868_ChIP-Seq_BL_Human | 1.35425621 |
| 48 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.33696461 |
| 49 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.33143752 |
| 50 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32381615 |
| 51 | CJUN_26792858_Chip-Seq_BT549_Human | 1.31193501 |
| 52 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.31193025 |
| 53 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.31022354 |
| 54 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.30243736 |
| 55 | MYB_26560356_Chip-Seq_TH1_Human | 1.29460803 |
| 56 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.28934870 |
| 57 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28665344 |
| 58 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27280596 |
| 59 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.27132923 |
| 60 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.27132923 |
| 61 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26666753 |
| 62 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25383879 |
| 63 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24867691 |
| 64 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.23413164 |
| 65 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.22433241 |
| 66 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.21934505 |
| 67 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.20989483 |
| 68 | * CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.20656702 |
| 69 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.20602061 |
| 70 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.20529848 |
| 71 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.19641191 |
| 72 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.17032002 |
| 73 | MAF_26560356_Chip-Seq_TH1_Human | 1.16947778 |
| 74 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.16270521 |
| 75 | MAF_26560356_Chip-Seq_TH2_Human | 1.15836785 |
| 76 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.15782418 |
| 77 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14424241 |
| 78 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14381091 |
| 79 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.13026027 |
| 80 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12913470 |
| 81 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.11071500 |
| 82 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.09883413 |
| 83 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.09883413 |
| 84 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.09773752 |
| 85 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09468095 |
| 86 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.08989115 |
| 87 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.08112161 |
| 88 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08034362 |
| 89 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.06251312 |
| 90 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.05785036 |
| 91 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04619566 |
| 92 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.04572834 |
| 93 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.04423257 |
| 94 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.03993279 |
| 95 | GATA1_19941826_ChIP-Seq_K562_Human | 1.03509102 |
| 96 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.01367152 |
| 97 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.00006786 |
| 98 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.99864207 |
| 99 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.99834185 |
| 100 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.99518804 |
| 101 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.97374277 |
| 102 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97120685 |
| 103 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.96769210 |
| 104 | MYB_26560356_Chip-Seq_TH2_Human | 0.96318891 |
| 105 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96232709 |
| 106 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.96116005 |
| 107 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95830424 |
| 108 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.95484701 |
| 109 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.95366924 |
| 110 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95058666 |
| 111 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94193867 |
| 112 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.93682532 |
| 113 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 0.93662086 |
| 114 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.93634993 |
| 115 | GATA1_22025678_ChIP-Seq_K562_Human | 0.92856863 |
| 116 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.92639242 |
| 117 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.92448948 |
| 118 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.91633806 |
| 119 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.90965937 |
| 120 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.90058305 |
| 121 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89900542 |
| 122 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89203356 |
| 123 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88929942 |
| 124 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.88896692 |
| 125 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88359287 |
| 126 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.85813796 |
| 127 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.85536477 |
| 128 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.84900299 |
| 129 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84448302 |
| 130 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.84225132 |
| 131 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.84205811 |
| 132 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.83948605 |
| 133 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.81779084 |
| 134 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81559747 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004510_myositis | 3.53316392 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.13466346 |
| 3 | MP0002837_dystrophic_cardiac_calcinosis | 3.10986456 |
| 4 | MP0003303_peritoneal_inflammation | 2.88179861 |
| 5 | MP0004084_abnormal_cardiac_muscle | 2.87122316 |
| 6 | MP0003436_decreased_susceptibility_to | 2.75735287 |
| 7 | MP0003646_muscle_fatigue | 2.66959305 |
| 8 | MP0009785_altered_susceptibility_to | 2.64122793 |
| 9 | * MP0002148_abnormal_hypersensitivity_rea | 2.60234809 |
| 10 | MP0003828_pulmonary_edema | 2.52217967 |
| 11 | MP0000343_altered_response_to | 2.29317592 |
| 12 | MP0000751_myopathy | 2.26304672 |
| 13 | MP0002419_abnormal_innate_immunity | 2.23429113 |
| 14 | MP0004215_abnormal_myocardial_fiber | 2.08377802 |
| 15 | MP0005058_abnormal_lysosome_morphology | 2.07158135 |
| 16 | MP0002972_abnormal_cardiac_muscle | 2.01501243 |
| 17 | MP0003300_gastrointestinal_ulcer | 1.96801187 |
| 18 | * MP0005000_abnormal_immune_tolerance | 1.95041448 |
| 19 | MP0005451_abnormal_body_composition | 1.91487145 |
| 20 | * MP0005025_abnormal_response_to | 1.89811887 |
| 21 | MP0004036_abnormal_muscle_relaxation | 1.86877837 |
| 22 | MP0001790_abnormal_immune_system | 1.86678716 |
| 23 | MP0005387_immune_system_phenotype | 1.86678716 |
| 24 | MP0005330_cardiomyopathy | 1.85401049 |
| 25 | MP0000685_abnormal_immune_system | 1.84187928 |
| 26 | MP0003191_abnormal_cellular_cholesterol | 1.80204374 |
| 27 | MP0006082_CNS_inflammation | 1.79694675 |
| 28 | * MP0002452_abnormal_antigen_presenting | 1.75304307 |
| 29 | MP0003724_increased_susceptibility_to | 1.71312566 |
| 30 | MP0008260_abnormal_autophagy | 1.69874450 |
| 31 | MP0000749_muscle_degeneration | 1.66899619 |
| 32 | MP0001533_abnormal_skeleton_physiology | 1.64875429 |
| 33 | MP0004484_altered_response_of | 1.64246025 |
| 34 | MP0004130_abnormal_muscle_cell | 1.61787602 |
| 35 | MP0005385_cardiovascular_system_phenoty | 1.61150951 |
| 36 | MP0001544_abnormal_cardiovascular_syste | 1.61150951 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.60868193 |
| 38 | MP0008438_abnormal_cutaneous_collagen | 1.60771505 |
| 39 | MP0009840_abnormal_foam_cell | 1.59107445 |
| 40 | MP0004087_abnormal_muscle_fiber | 1.58981533 |
| 41 | MP0001853_heart_inflammation | 1.58976804 |
| 42 | MP0001800_abnormal_humoral_immune | 1.56953607 |
| 43 | MP0008775_abnormal_heart_ventricle | 1.53925084 |
| 44 | MP0002723_abnormal_immune_serum | 1.49268773 |
| 45 | MP0001545_abnormal_hematopoietic_system | 1.47471832 |
| 46 | MP0005397_hematopoietic_system_phenotyp | 1.47471832 |
| 47 | MP0002166_altered_tumor_susceptibility | 1.44024362 |
| 48 | MP0010630_abnormal_cardiac_muscle | 1.42859307 |
| 49 | MP0002139_abnormal_hepatobiliary_system | 1.42360644 |
| 50 | MP0003279_aneurysm | 1.42324122 |
| 51 | * MP0001819_abnormal_immune_cell | 1.41444592 |
| 52 | MP0005671_abnormal_response_to | 1.40842549 |
| 53 | MP0005620_abnormal_muscle_contractility | 1.39067845 |
| 54 | * MP0002420_abnormal_adaptive_immunity | 1.38393249 |
| 55 | MP0009764_decreased_sensitivity_to | 1.36057970 |
| 56 | MP0008004_abnormal_stomach_pH | 1.35630251 |
| 57 | MP0000750_abnormal_muscle_regeneration | 1.34770021 |
| 58 | MP0002138_abnormal_hepatobiliary_system | 1.34416331 |
| 59 | MP0005464_abnormal_platelet_physiology | 1.32637867 |
| 60 | MP0001845_abnormal_inflammatory_respons | 1.32386240 |
| 61 | MP0003690_abnormal_glial_cell | 1.30883370 |
| 62 | MP0009333_abnormal_splenocyte_physiolog | 1.30194266 |
| 63 | MP0003566_abnormal_cell_adhesion | 1.29415286 |
| 64 | MP0006138_congestive_heart_failure | 1.28123318 |
| 65 | MP0003806_abnormal_nucleotide_metabolis | 1.27081306 |
| 66 | MP0000465_gastrointestinal_hemorrhage | 1.26807014 |
| 67 | MP0003705_abnormal_hypodermis_morpholog | 1.26137177 |
| 68 | MP0005310_abnormal_salivary_gland | 1.26056101 |
| 69 | MP0002405_respiratory_system_inflammati | 1.23885663 |
| 70 | MP0003075_altered_response_to | 1.23773453 |
| 71 | MP0002998_abnormal_bone_remodeling | 1.23472456 |
| 72 | MP0002006_tumorigenesis | 1.22589727 |
| 73 | MP0004947_skin_inflammation | 1.22519131 |
| 74 | MP0005166_decreased_susceptibility_to | 1.22490016 |
| 75 | MP0003172_abnormal_lysosome_physiology | 1.21811555 |
| 76 | MP0003453_abnormal_keratinocyte_physiol | 1.21740444 |
| 77 | MP0000604_amyloidosis | 1.20945087 |
| 78 | MP0002106_abnormal_muscle_physiology | 1.18164180 |
| 79 | MP0002254_reproductive_system_inflammat | 1.18004331 |
| 80 | MP0003221_abnormal_cardiomyocyte_apopto | 1.17973585 |
| 81 | * MP0002398_abnormal_bone_marrow | 1.16528565 |
| 82 | MP0008469_abnormal_protein_level | 1.16429430 |
| 83 | MP0003448_altered_tumor_morphology | 1.13525936 |
| 84 | MP0001958_emphysema | 1.12344481 |
| 85 | MP0005167_abnormal_blood-brain_barrier | 1.10684791 |
| 86 | MP0003045_fibrosis | 1.08168938 |
| 87 | MP0003137_abnormal_impulse_conducting | 1.07743519 |
| 88 | MP0005165_increased_susceptibility_to | 1.06501377 |
| 89 | MP0003183_abnormal_peptide_metabolism | 1.05438334 |
| 90 | MP0000689_abnormal_spleen_morphology | 1.05354026 |
| 91 | * MP0002429_abnormal_blood_cell | 1.04753075 |
| 92 | MP0000767_abnormal_smooth_muscle | 1.04170796 |
| 93 | MP0003656_abnormal_erythrocyte_physiolo | 1.02690849 |
| 94 | MP0000249_abnormal_blood_vessel | 1.00463069 |
| 95 | MP0004858_abnormal_nervous_system | 0.99239961 |
| 96 | MP0006054_spinal_hemorrhage | 0.98847601 |
| 97 | MP0002277_abnormal_respiratory_mucosa | 0.98077297 |
| 98 | MP0000858_altered_metastatic_potential | 0.98074620 |
| 99 | MP0001879_abnormal_lymphatic_vessel | 0.97738331 |
| 100 | MP0002722_abnormal_immune_system | 0.97478369 |
| 101 | MP0003866_abnormal_defecation | 0.96611717 |
| 102 | MP0003091_abnormal_cell_migration | 0.93325523 |
| 103 | MP0004782_abnormal_surfactant_physiolog | 0.92611996 |
| 104 | MP0009763_increased_sensitivity_to | 0.92158061 |
| 105 | MP0001663_abnormal_digestive_system | 0.90673578 |
| 106 | MP0009278_abnormal_bone_marrow | 0.90612127 |
| 107 | MP0003329_amyloid_beta_deposits | 0.87494216 |
| 108 | MP0003763_abnormal_thymus_physiology | 0.86769245 |
| 109 | MP0001851_eye_inflammation | 0.85833323 |
| 110 | * MP0000716_abnormal_immune_system | 0.85089982 |
| 111 | MP0003795_abnormal_bone_structure | 0.83394718 |
| 112 | MP0005164_abnormal_response_to | 0.82214338 |
| 113 | MP0002877_abnormal_melanocyte_morpholog | 0.80823250 |
| 114 | MP0002132_abnormal_respiratory_system | 0.80785998 |
| 115 | MP0005275_abnormal_skin_tensile | 0.80599452 |
| 116 | MP0001873_stomach_inflammation | 0.79692076 |
| 117 | MP0000759_abnormal_skeletal_muscle | 0.79200328 |
| 118 | MP0005369_muscle_phenotype | 0.79179553 |
| 119 | MP0000920_abnormal_myelination | 0.79030514 |
| 120 | MP0002332_abnormal_exercise_endurance | 0.78875878 |
| 121 | MP0010234_abnormal_vibrissa_follicle | 0.78260641 |
| 122 | MP0010368_abnormal_lymphatic_system | 0.77496471 |
| 123 | MP0004883_abnormal_blood_vessel | 0.76000210 |
| 124 | MP0005023_abnormal_wound_healing | 0.75907363 |
| 125 | MP0004085_abnormal_heartbeat | 0.75004938 |
| 126 | MP0009765_abnormal_xenobiotic_induced | 0.74538436 |
| 127 | MP0005390_skeleton_phenotype | 0.73550458 |
| 128 | MP0001542_abnormal_bone_strength | 0.72467731 |
| 129 | MP0002933_joint_inflammation | 0.63986623 |
| 130 | MP0008874_decreased_physiological_sensi | 0.63870049 |
| 131 | MP0000609_abnormal_liver_physiology | 0.61578087 |
| 132 | MP0000490_abnormal_crypts_of | 0.61524943 |
| 133 | MP0005319_abnormal_enzyme/_coenzyme | 0.60544622 |
| 134 | MP0000371_diluted_coat_color | 0.57315803 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 4.88993449 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.79082564 |
| 3 | Sudden death (HP:0001699) | 4.66576729 |
| 4 | Ventricular tachycardia (HP:0004756) | 4.58452648 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 4.34697556 |
| 6 | Right ventricular cardiomyopathy (HP:0011663) | 4.26223972 |
| 7 | Loss of speech (HP:0002371) | 3.73603652 |
| 8 | Asymmetric septal hypertrophy (HP:0001670) | 3.54564559 |
| 9 | Exercise-induced muscle cramps (HP:0003710) | 3.54308920 |
| 10 | Atrial fibrillation (HP:0005110) | 3.53817591 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.45351933 |
| 12 | Lipoatrophy (HP:0100578) | 3.44304830 |
| 13 | Systemic lupus erythematosus (HP:0002725) | 3.39815286 |
| 14 | Amyloidosis (HP:0011034) | 3.36267176 |
| 15 | Primary atrial arrhythmia (HP:0001692) | 3.36045210 |
| 16 | Syncope (HP:0001279) | 3.26423085 |
| 17 | Supraventricular tachycardia (HP:0004755) | 3.16313050 |
| 18 | Increased cerebral lipofuscin (HP:0011813) | 3.11520657 |
| 19 | Gingivitis (HP:0000230) | 3.11492678 |
| 20 | Supraventricular arrhythmia (HP:0005115) | 3.11025562 |
| 21 | Calf muscle hypertrophy (HP:0008981) | 3.09333189 |
| 22 | Keratoconjunctivitis sicca (HP:0001097) | 3.05942332 |
| 23 | Abnormality of macrophages (HP:0004311) | 3.05672859 |
| 24 | Palpitations (HP:0001962) | 2.92630822 |
| 25 | Vacuolated lymphocytes (HP:0001922) | 2.90180519 |
| 26 | Gastrointestinal infarctions (HP:0005244) | 2.88925123 |
| 27 | Abnormality of the calf musculature (HP:0001430) | 2.84927206 |
| 28 | Hematochezia (HP:0002573) | 2.80664128 |
| 29 | Meningitis (HP:0001287) | 2.79931458 |
| 30 | Autoimmune thrombocytopenia (HP:0001973) | 2.79660828 |
| 31 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.78602952 |
| 32 | Pulmonary infiltrates (HP:0002113) | 2.78178065 |
| 33 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.75280716 |
| 34 | Keratoconjunctivitis (HP:0001096) | 2.75003679 |
| 35 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.74652923 |
| 36 | Myositis (HP:0100614) | 2.74169558 |
| 37 | EMG: myopathic abnormalities (HP:0003458) | 2.70515499 |
| 38 | Exercise-induced myalgia (HP:0003738) | 2.70204496 |
| 39 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.68795741 |
| 40 | Subaortic stenosis (HP:0001682) | 2.68795741 |
| 41 | Hemoptysis (HP:0002105) | 2.67819554 |
| 42 | Bundle branch block (HP:0011710) | 2.65251773 |
| 43 | Mediastinal lymphadenopathy (HP:0100721) | 2.63959631 |
| 44 | Mutism (HP:0002300) | 2.62857739 |
| 45 | Axonal loss (HP:0003447) | 2.62251107 |
| 46 | Ventricular arrhythmia (HP:0004308) | 2.60217053 |
| 47 | Pustule (HP:0200039) | 2.60044824 |
| 48 | Increased connective tissue (HP:0009025) | 2.57538703 |
| 49 | Dilated cardiomyopathy (HP:0001644) | 2.57367152 |
| 50 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.56894595 |
| 51 | Increased IgE level (HP:0003212) | 2.55989312 |
| 52 | Purpura (HP:0000979) | 2.54881457 |
| 53 | Petechiae (HP:0000967) | 2.53979989 |
| 54 | Recurrent skin infections (HP:0001581) | 2.51346886 |
| 55 | Malnutrition (HP:0004395) | 2.50963588 |
| 56 | Orchitis (HP:0100796) | 2.50858807 |
| 57 | Facial diplegia (HP:0001349) | 2.49660309 |
| 58 | Muscle fiber splitting (HP:0003555) | 2.48195819 |
| 59 | Recurrent fungal infections (HP:0002841) | 2.46485032 |
| 60 | Cellulitis (HP:0100658) | 2.45707324 |
| 61 | Neurofibrillary tangles (HP:0002185) | 2.43816790 |
| 62 | Prolonged QT interval (HP:0001657) | 2.42490386 |
| 63 | Increased serum ferritin (HP:0003281) | 2.41566806 |
| 64 | Encephalitis (HP:0002383) | 2.38780353 |
| 65 | Glomerulonephritis (HP:0000099) | 2.35076521 |
| 66 | Obstructive lung disease (HP:0006536) | 2.33504696 |
| 67 | Chronic obstructive pulmonary disease (HP:0006510) | 2.33504696 |
| 68 | Ventricular fibrillation (HP:0001663) | 2.32814843 |
| 69 | Hepatosplenomegaly (HP:0001433) | 2.29381822 |
| 70 | Dysostosis multiplex (HP:0000943) | 2.27992136 |
| 71 | Hyporeflexia of lower limbs (HP:0002600) | 2.27451114 |
| 72 | Recurrent cutaneous fungal infections (HP:0011370) | 2.26937293 |
| 73 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.26937293 |
| 74 | Progressive neurologic deterioration (HP:0002344) | 2.25903553 |
| 75 | Episodic fever (HP:0001954) | 2.24351101 |
| 76 | Interstitial pulmonary disease (HP:0006530) | 2.23370650 |
| 77 | Myoglobinuria (HP:0002913) | 2.23218513 |
| 78 | Urticaria (HP:0001025) | 2.21790806 |
| 79 | Periodontitis (HP:0000704) | 2.21531006 |
| 80 | Arterial thrombosis (HP:0004420) | 2.20821525 |
| 81 | Esophageal neoplasm (HP:0100751) | 2.18767124 |
| 82 | Neoplasm of head and neck (HP:0012288) | 2.18767124 |
| 83 | Upper motor neuron abnormality (HP:0002127) | 2.17824003 |
| 84 | Chest pain (HP:0100749) | 2.17291151 |
| 85 | Disinhibition (HP:0000734) | 2.16352795 |
| 86 | Vertebral compression fractures (HP:0002953) | 2.16260761 |
| 87 | Tetraparesis (HP:0002273) | 2.16048828 |
| 88 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.15357430 |
| 89 | Nephritis (HP:0000123) | 2.14453087 |
| 90 | Gangrene (HP:0100758) | 2.13836920 |
| 91 | Bone cyst (HP:0012062) | 2.12849146 |
| 92 | Premature loss of primary teeth (HP:0006323) | 2.12451026 |
| 93 | Abnormality of proline metabolism (HP:0010907) | 2.12114903 |
| 94 | Hydroxyprolinuria (HP:0003080) | 2.12114903 |
| 95 | Conjunctival hamartoma (HP:0100780) | 2.10714965 |
| 96 | Anorexia (HP:0002039) | 2.09851839 |
| 97 | Neuronal loss in central nervous system (HP:0002529) | 2.09049542 |
| 98 | Colitis (HP:0002583) | 2.07745650 |
| 99 | Spontaneous hematomas (HP:0007420) | 2.06713026 |
| 100 | Gingival bleeding (HP:0000225) | 2.05568053 |
| 101 | Abnormality of iron homeostasis (HP:0011031) | 2.04568603 |
| 102 | Pulmonary embolism (HP:0002204) | 2.04057352 |
| 103 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.04050229 |
| 104 | Polyneuropathy (HP:0001271) | 2.03138715 |
| 105 | Distal lower limb muscle weakness (HP:0009053) | 2.01248339 |
| 106 | Thick nail (HP:0001805) | 1.99599525 |
| 107 | Inflammation of the large intestine (HP:0002037) | 1.99432983 |
| 108 | Pathologic fracture (HP:0002756) | 1.99033011 |
| 109 | Abnormality of glycolipid metabolism (HP:0010969) | 1.98283877 |
| 110 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.98283877 |
| 111 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.98283877 |
| 112 | Sudden cardiac death (HP:0001645) | 1.97823165 |
| 113 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.97374939 |
| 114 | Glomerulopathy (HP:0100820) | 1.96990578 |
| 115 | Abnormal atrioventricular conduction (HP:0005150) | 1.96684364 |
| 116 | Abnormality of complement system (HP:0005339) | 1.95937017 |
| 117 | Diminished motivation (HP:0000745) | 1.95352123 |
| 118 | Optic neuritis (HP:0100653) | 1.95014471 |
| 119 | Retrobulbar optic neuritis (HP:0100654) | 1.95014471 |
| 120 | Abnormality of the pleura (HP:0002103) | 1.94929037 |
| 121 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.93796386 |
| 122 | Mucopolysacchariduria (HP:0008155) | 1.93796386 |
| 123 | Osteomyelitis (HP:0002754) | 1.92741395 |
| 124 | Stomatitis (HP:0010280) | 1.92320116 |
| 125 | Basal ganglia calcification (HP:0002135) | 1.92226607 |
| 126 | Increased CSF protein (HP:0002922) | 1.91661297 |
| 127 | Leukocytosis (HP:0001974) | 1.91315070 |
| 128 | Heart block (HP:0012722) | 1.91137122 |
| 129 | Epistaxis (HP:0000421) | 1.90327285 |
| 130 | Apathy (HP:0000741) | 1.90216959 |
| 131 | Restrictive lung disease (HP:0002091) | 1.89463166 |
| 132 | Frequent falls (HP:0002359) | 1.89355903 |
| 133 | Vasculitis (HP:0002633) | 1.88998873 |
| 134 | Complement deficiency (HP:0004431) | 1.88995203 |
| 135 | Nuclear cataract (HP:0100018) | 1.88622064 |
| 136 | Myocardial infarction (HP:0001658) | 1.88084319 |
| 137 | Abnormal EKG (HP:0003115) | 1.86919025 |
| 138 | Hypergammaglobulinemia (HP:0010702) | 1.86409779 |
| 139 | Prolonged bleeding time (HP:0003010) | 1.86119006 |
| 140 | Peritonitis (HP:0002586) | 1.85254884 |
| 141 | Myotonia (HP:0002486) | 1.84723412 |
| 142 | Recurrent viral infections (HP:0004429) | 1.84161795 |
| 143 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.80504693 |
| 144 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.80504693 |
| 145 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.80504693 |
| 146 | Gastrointestinal stroma tumor (HP:0100723) | 1.80410771 |
| 147 | Nausea (HP:0002018) | 1.80330528 |
| 148 | Cerebral aneurysm (HP:0004944) | 1.78091421 |
| 149 | Gastrointestinal inflammation (HP:0004386) | 1.77968005 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 3.27622172 |
| 2 | LMTK2 | 3.04202571 |
| 3 | MAP3K14 | 2.90218399 |
| 4 | RIPK4 | 2.82015948 |
| 5 | BLK | 2.81203797 |
| 6 | MYLK | 2.66950238 |
| 7 | TBK1 | 2.66569324 |
| 8 | PRPF4B | 2.29410349 |
| 9 | TYK2 | 2.24552870 |
| 10 | DMPK | 2.13649233 |
| 11 | ERN1 | 2.13509495 |
| 12 | PKN2 | 2.10217466 |
| 13 | IRAK4 | 2.09291489 |
| 14 | IRAK3 | 2.02878866 |
| 15 | TRIB3 | 2.01120827 |
| 16 | TGFBR2 | 1.99086557 |
| 17 | PIK3CA | 1.97559932 |
| 18 | TAOK1 | 1.93200866 |
| 19 | NEK9 | 1.91658738 |
| 20 | RIPK1 | 1.83579082 |
| 21 | TAOK2 | 1.75233775 |
| 22 | IKBKE | 1.64853826 |
| 23 | PHKG1 | 1.63656687 |
| 24 | PHKG2 | 1.63656687 |
| 25 | GRK7 | 1.62517847 |
| 26 | KIT | 1.59331721 |
| 27 | PIM2 | 1.59085395 |
| 28 | JAK1 | 1.56599666 |
| 29 | STK24 | 1.44641044 |
| 30 | SIK3 | 1.44637016 |
| 31 | DDR2 | 1.42194651 |
| 32 | FRK | 1.39877063 |
| 33 | JAK3 | 1.36475533 |
| 34 | MAP4K1 | 1.30322384 |
| 35 | BMPR2 | 1.29710452 |
| 36 | IKBKB | 1.28666548 |
| 37 | EPHA3 | 1.24230107 |
| 38 | CDC42BPA | 1.21015565 |
| 39 | EPHB1 | 1.20791028 |
| 40 | KSR2 | 1.16538740 |
| 41 | OBSCN | 1.13443243 |
| 42 | TNK2 | 1.09391181 |
| 43 | TESK2 | 1.08106507 |
| 44 | TESK1 | 1.05847727 |
| 45 | TRPM7 | 1.05100314 |
| 46 | MOS | 1.03616022 |
| 47 | MATK | 1.00946761 |
| 48 | IRAK1 | 0.99122461 |
| 49 | MAP3K12 | 0.98262582 |
| 50 | CSK | 0.98051195 |
| 51 | SYK | 0.97847568 |
| 52 | MST1R | 0.97663293 |
| 53 | IRAK2 | 0.95869419 |
| 54 | ZAP70 | 0.94960166 |
| 55 | CHUK | 0.92096309 |
| 56 | MAP3K5 | 0.89104250 |
| 57 | TEC | 0.87923212 |
| 58 | PTK6 | 0.86583904 |
| 59 | ACVR1B | 0.86533801 |
| 60 | CSF1R | 0.85313461 |
| 61 | HCK | 0.84432723 |
| 62 | MAP2K3 | 0.84253636 |
| 63 | DAPK3 | 0.84164008 |
| 64 | PTK2B | 0.82636327 |
| 65 | PRKG2 | 0.82155642 |
| 66 | JAK2 | 0.77405204 |
| 67 | MST4 | 0.73407678 |
| 68 | MARK3 | 0.72699470 |
| 69 | ILK | 0.71758427 |
| 70 | YES1 | 0.71673892 |
| 71 | CAMKK2 | 0.70967178 |
| 72 | MAP3K11 | 0.69267062 |
| 73 | MAP3K2 | 0.66199819 |
| 74 | BTK | 0.64656859 |
| 75 | TXK | 0.64240007 |
| 76 | NME2 | 0.63889730 |
| 77 | KSR1 | 0.63293580 |
| 78 | EPHB2 | 0.63128737 |
| 79 | PRKD2 | 0.62470982 |
| 80 | MAP3K6 | 0.61908056 |
| 81 | ARAF | 0.61641700 |
| 82 | PDK2 | 0.61374607 |
| 83 | FGFR3 | 0.60954295 |
| 84 | TAOK3 | 0.60857218 |
| 85 | MARK2 | 0.60543596 |
| 86 | MAP3K10 | 0.60507158 |
| 87 | FGFR4 | 0.59419536 |
| 88 | PRKCD | 0.58438224 |
| 89 | FGR | 0.57967327 |
| 90 | LRRK2 | 0.57197933 |
| 91 | ERBB3 | 0.57067678 |
| 92 | PDK4 | 0.55947349 |
| 93 | PDK3 | 0.55947349 |
| 94 | MAPK12 | 0.55546069 |
| 95 | RPS6KA2 | 0.53109341 |
| 96 | LYN | 0.52923298 |
| 97 | MAP2K6 | 0.52509045 |
| 98 | FLT3 | 0.51987507 |
| 99 | MAP3K3 | 0.51408496 |
| 100 | STK10 | 0.50970130 |
| 101 | CAMK1D | 0.50707879 |
| 102 | ABL2 | 0.49618547 |
| 103 | MAPK7 | 0.48182746 |
| 104 | PIM1 | 0.47800256 |
| 105 | GRK6 | 0.47297266 |
| 106 | PAK3 | 0.47168526 |
| 107 | LCK | 0.47138593 |
| 108 | MAP2K2 | 0.46921896 |
| 109 | FES | 0.46490152 |
| 110 | BMX | 0.46261034 |
| 111 | MAP3K13 | 0.45926543 |
| 112 | ROCK1 | 0.45800632 |
| 113 | MAP3K1 | 0.45421680 |
| 114 | TIE1 | 0.45132276 |
| 115 | RPS6KA6 | 0.44157070 |
| 116 | PRKD1 | 0.44125007 |
| 117 | CAMK2D | 0.43753736 |
| 118 | CDK6 | 0.43123635 |
| 119 | FYN | 0.43044089 |
| 120 | NUAK1 | 0.42488204 |
| 121 | LIMK1 | 0.42401238 |
| 122 | PDPK1 | 0.41973637 |
| 123 | RPS6KL1 | 0.41857937 |
| 124 | RPS6KC1 | 0.41857937 |
| 125 | PAK4 | 0.41659494 |
| 126 | MAPKAPK2 | 0.40540073 |
| 127 | MAP3K7 | 0.39755769 |
| 128 | PDK1 | 0.38601437 |
| 129 | RAF1 | 0.37964356 |
| 130 | HIPK2 | 0.34389880 |
| 131 | DAPK2 | 0.33264210 |
| 132 | SGK3 | 0.32996609 |
| 133 | ABL1 | 0.32593328 |
| 134 | MAP3K8 | 0.31844194 |
| 135 | ITK | 0.30529603 |
| 136 | DYRK1B | 0.27907417 |
| 137 | MAPK4 | 0.27741087 |
| 138 | SIK1 | 0.27689838 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Leishmaniasis_Homo sapiens_hsa05140 | 2.52739309 |
| 2 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.12821970 |
| 3 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.08862328 |
| 4 | Viral myocarditis_Homo sapiens_hsa05416 | 1.97877059 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.96170032 |
| 6 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.90712537 |
| 7 | Pertussis_Homo sapiens_hsa05133 | 1.88621032 |
| 8 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.88256279 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.86251325 |
| 10 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.81877177 |
| 11 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.76440362 |
| 12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.74907477 |
| 13 | * Tuberculosis_Homo sapiens_hsa05152 | 1.73273420 |
| 14 | Legionellosis_Homo sapiens_hsa05134 | 1.67756450 |
| 15 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.61216027 |
| 16 | * Salmonella infection_Homo sapiens_hsa05132 | 1.60498058 |
| 17 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.58949873 |
| 18 | Malaria_Homo sapiens_hsa05144 | 1.46972602 |
| 19 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.43046764 |
| 20 | Lysosome_Homo sapiens_hsa04142 | 1.41786011 |
| 21 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.41738156 |
| 22 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.40825047 |
| 23 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.36419651 |
| 24 | Phagosome_Homo sapiens_hsa04145 | 1.32425861 |
| 25 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.31090541 |
| 26 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.29211259 |
| 27 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.29110994 |
| 28 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.26438769 |
| 29 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.25184468 |
| 30 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.24898189 |
| 31 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.23358719 |
| 32 | * Influenza A_Homo sapiens_hsa05164 | 1.22612817 |
| 33 | Other glycan degradation_Homo sapiens_hsa00511 | 1.20438238 |
| 34 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.19940595 |
| 35 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.16224626 |
| 36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.15366432 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 1.13339083 |
| 38 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.12823753 |
| 39 | Amoebiasis_Homo sapiens_hsa05146 | 1.10809890 |
| 40 | * Measles_Homo sapiens_hsa05162 | 1.10448467 |
| 41 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.07884220 |
| 42 | Apoptosis_Homo sapiens_hsa04210 | 1.05852889 |
| 43 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.05777276 |
| 44 | Mineral absorption_Homo sapiens_hsa04978 | 1.03641152 |
| 45 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.03372441 |
| 46 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.98084016 |
| 47 | Allograft rejection_Homo sapiens_hsa05330 | 0.96911838 |
| 48 | Alzheimers disease_Homo sapiens_hsa05010 | 0.96885121 |
| 49 | Parkinsons disease_Homo sapiens_hsa05012 | 0.96641324 |
| 50 | * Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.96620774 |
| 51 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.90691359 |
| 52 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.89946019 |
| 53 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.88681948 |
| 54 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.88529398 |
| 55 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.88265249 |
| 56 | Platelet activation_Homo sapiens_hsa04611 | 0.86224687 |
| 57 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.84694895 |
| 58 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.82093466 |
| 59 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.81640981 |
| 60 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.80976857 |
| 61 | Focal adhesion_Homo sapiens_hsa04510 | 0.79477902 |
| 62 | Asthma_Homo sapiens_hsa05310 | 0.79135428 |
| 63 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.78649287 |
| 64 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.77091275 |
| 65 | Prion diseases_Homo sapiens_hsa05020 | 0.76740251 |
| 66 | Hepatitis C_Homo sapiens_hsa05160 | 0.76637690 |
| 67 | Bladder cancer_Homo sapiens_hsa05219 | 0.75991491 |
| 68 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.75077667 |
| 69 | Hepatitis B_Homo sapiens_hsa05161 | 0.75058066 |
| 70 | * HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.74911030 |
| 71 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.74651806 |
| 72 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.74319333 |
| 73 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.72890402 |
| 74 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.72698529 |
| 75 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.72667309 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.71454722 |
| 77 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.71369551 |
| 78 | Galactose metabolism_Homo sapiens_hsa00052 | 0.70890984 |
| 79 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.70503932 |
| 80 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.70296605 |
| 81 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.70114718 |
| 82 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.69337721 |
| 83 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67330902 |
| 84 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.67144929 |
| 85 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.66950232 |
| 86 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.65726086 |
| 87 | Endocytosis_Homo sapiens_hsa04144 | 0.63964806 |
| 88 | Insulin resistance_Homo sapiens_hsa04931 | 0.63827601 |
| 89 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.63740244 |
| 90 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.63370663 |
| 91 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.62831075 |
| 92 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.62726545 |
| 93 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.61722412 |
| 94 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.61488939 |
| 95 | Adherens junction_Homo sapiens_hsa04520 | 0.60718997 |
| 96 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.58980903 |
| 97 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.58607704 |
| 98 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.57784852 |
| 99 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.57008414 |
| 100 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.56732601 |
| 101 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.54260210 |
| 102 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.54059002 |
| 103 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.53681165 |
| 104 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.52917469 |
| 105 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.52751924 |
| 106 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.51062517 |
| 107 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.48263515 |
| 108 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.47577867 |
| 109 | * Herpes simplex infection_Homo sapiens_hsa05168 | 0.44175009 |
| 110 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.43613624 |
| 111 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.43047019 |
| 112 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42551745 |
| 113 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.41374893 |
| 114 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.40773271 |
| 115 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.40744344 |
| 116 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.40199617 |
| 117 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.39213802 |
| 118 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.39066680 |
| 119 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.37188790 |
| 120 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.36566479 |
| 121 | HTLV-I infection_Homo sapiens_hsa05166 | 0.35262588 |
| 122 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.31530368 |
| 123 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.30128175 |
| 124 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.29708480 |
| 125 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.26549037 |
| 126 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.25639211 |

